Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Eversense 365 is said to be the world's first one-year CGM system, offering a new long-term solution for diabetes management.

A threatened Oct. 1 strike by dockworkers at ports on the U.S. East Coast and Gulf of Mexico would immediately disrupt the ...

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

Neither Gene Seroka nor George Goldman saw evidence that East Coast-bound vessels will be diverted after a possible Oct. 1 ...

After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...

Veri, which makes a continuous glucose monitor, has announced that it has joined ŌURA, which makes the Oura Ring.

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...

Dexcom Inc. revealed data from several studies showing significant benefits of its continuous glucose monitoring technology ...

A threatened Oct. 1 strike by dockworkers at ports on the U.S. East Coast and Gulf of Mexico would immediately disrupt the ...